Healthcare-associated infections and their prevention after extensive flooding

被引:4
|
作者
Apisarnthanarak, Anucha [1 ]
Warren, David K. [2 ]
Mayhall, Clovus Glen [3 ]
机构
[1] Thammasat Univ Hosp, Div Infect Dis, Pathum Thani 12120, Thailand
[2] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA
[3] Univ Texas Med Branch, Dept Healthcare Epidemiol, Galveston, TX 77555 USA
关键词
black water; cross infection; floods; hospital; infection control; infections; PSEUDO-OUTBREAK; TSUNAMI SURVIVORS; AIR-POLLUTION; WATER; CONTAMINATION; ENVIRONMENTS; IMPACTS;
D O I
10.1097/QCO.0b013e3283630b1d
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of reviewThis review will focus on the epidemiology of healthcare-associated infections (HAIs) after extensive blackwater flooding as well as preventive measures.Recent findingsThere is evidence suggesting an increased incidence of HAIs and pseudo-outbreaks due to molds after extensive flooding in healthcare facilities. However, there is no strong evidence of an increased incidence of typical nosocomial infections (i.e., ventilator-associated pneumonia, healthcare-associated pneumonia, central line-associated bloodstream infection and catheter-associated urinary tract infections). The prevalence of multidrug-resistant organisms may decrease after extensive flooding, due to repeated and thorough environmental cleaning prior to re-opening hospitals. Contamination of hospital water sources by enteric Gram-negative bacteria (e.g., Aeromonas species), Legionella species and nontuberculous Mycobacterium species in flood-affected hospitals has been reported. Surveillance is an important initial step to detect potential outbreaks/pseudo-outbreaks of HAIs. Hospital preparedness policies before extensive flooding, particularly with environmental cleaning and mold remediation, are key to reducing the risk of flood-related HAIs. These policies are still lacking in most hospitals in countries that have experienced or are at risk for extensive flooding, which argues for nationwide policies to strengthen preparedness planning.SummaryAdditional studies are needed to evaluate the epidemiology of flood-related HAIs and the optimal surveillance and control methods following extensive flooding.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 50 条
  • [41] Variations in Identification of Healthcare-Associated Infections
    Keller, Sara C.
    Linkin, Darren R.
    Fishman, Neil O.
    Lautenbach, Ebbing
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (07): : 678 - 686
  • [42] The role of water in healthcare-associated infections
    Decker, Brooke K.
    Palmore, Tara N.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2013, 26 (04) : 345 - 351
  • [43] Preventing and controlling healthcare-associated infections
    不详
    [J]. LANCET, 2008, 372 (9656): : 2088 - 2088
  • [44] Healthcare-associated infections in rheumatology in Japan
    Masahiro Iwamoto
    Takeshi Kamimura
    Takao Nagashima
    Yasuyuki Kamata
    Yoko Aoki
    Sachiko Onishi
    Seiji Minota
    [J]. Rheumatology International, 2012, 32 : 801 - 804
  • [45] Impact of organizations on healthcare-associated infections
    Castro-Sanchez, E.
    Holmes, A. H.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2015, 89 (04) : 346 - 350
  • [46] Legal liability for healthcare-associated infections
    Zielinski, Grzegorz
    Kanecki, Krzysztof
    Lewtak, Katarzyna
    [J]. FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2022, 24 (02): : 172 - 176
  • [47] PATIENT SAFETY AND HEALTHCARE-ASSOCIATED INFECTIONS
    Yaneva-Deliverska, M.
    [J]. JOURNAL OF IMAB, 2011, 17 (01): : 120 - 122
  • [48] Healthcare-associated infections in rheumatology in Japan
    Iwamoto, Masahiro
    Kamimura, Takeshi
    Nagashima, Takao
    Kamata, Yasuyuki
    Aoki, Yoko
    Onishi, Sachiko
    Minota, Seiji
    [J]. RHEUMATOLOGY INTERNATIONAL, 2012, 32 (03) : 801 - 804
  • [49] Controlling healthcare-associated infections in the NHS
    Duerden, Brian
    [J]. CLINICAL MEDICINE, 2008, 8 (02) : 140 - 143
  • [50] Prevention and detection of healthcare-associated infections using the comprehensive risk management system
    Konova, O.
    Payushchik, S.
    Kleymenova, E.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S14 - S14